Largest-ever type 1 diabetes genetic study IDs potential treatment targets (IMAGE)

University of Virginia Health System

Largest-ever type 1 diabetes genetic study IDs potential treatment targets

Caption

"This work represents the largest, most ancesty-diverse study of type 1 diabetes that identifies the most likely causal genetic variants associated with risk, their target genes and those genes that are implicated in other autoimmune diseases with known drug targets," said researcher Stephen S. Rich, PhD, of the University of Virginia School of Medicine and its Center for Public Health Genomics.

Credit

UVA Health

Usage Restrictions

May be used to accompany news coverage of the diabetes study. All other uses require express written permission from UVA Health.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.